Children and adolescents Safety and effectiveness in patients under 18 have not been established outside of trial settings
The transition between medications is typically straightforward: finish semaglutide, wait about a week, then start tirzepatide at a low dose
Standard daily dose: 250 mcg total blend once daily for 4 weeks or longer
The report authors noted that people may stop treatment before six weeks because of early side effects
Powell-Wiley TM, Poirier P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ et al (2021) Obesity and cardiovascular disease: a scientific statement from the american heart association
[1] [2] Unlike phentermine's central nervous system stimulation, tirzepatide works through multiple mechanisms: it enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through central pathways